MedTrace Logo

MED in UVB Devices in the Presence and Absence of UV Filter

NCT03049319 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-08-29

No results posted yet for this study

Summary

Psoriasis affects 2-3% of the American population. While a wide variety of therapies currently exist, including topical corticosteroids and Vit D analogs, oral immunosuppressant and retinoid agents a better understanding of phototherapy is needed. Given the prevalence of localized psoriasis and dissatisfaction with treatment, investigation of localized treatment should be a priority for researchers with goals to improve the current standard of care.

Conditions

  • Healthy Participants and/or Patients

Interventions

DEVICE

Psoriashield in the presence of a non-UV absorbing block.

The psoriashield will be applied to patient's back in the presence of a non-UV absorbing block.

DEVICE

Psoriashield in the presence of a UV absorbing block.

The psoriashield will be applied to patient's back in the presence of a UV absorbing block.

DEVICE

Psoriashield

The psoriashield will be applied to patient's back.

DEVICE

Xtrac laser in the presence of a non-UV absorbing block.

The Xtrac laser will be applied to patient's back in the presence of a UV absorbing block.

DEVICE

Xtrac in the presence of a UV absorbing block.

The Xtrac laser will be applied to patient's back in the presence of a non-UV absorbing block.

DEVICE

Xtrac laser

The Xtrac laser will be applied to patient's back.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Steven R Feldman, MD PhD · Wake Forest University Health Sciences

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-01-17
Completion
2019-01-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03049319 on ClinicalTrials.gov